Hence, integration of p16ink4a / ki-67 assay as a point of care test to be used specifically to identify at one visit, cases of cervical dysplasia with subsequent cryotherapy treatment, is an option extensively under investigation [28, 31, 63]. The gene discussed is PSME3; the disease is cervical intraepithelial neoplasia.